Swing Therapeutics Announces The Lancet Publication of Data from Phase 3 Trial of Stanza™ – a Digital Behavioral Therapy for Fibromyalgia Symptoms

SAN FRANCISCO–(BUSINESS WIRE)–The smartphone-based program for fibromyalgia demonstrated significant improvements compared to an active control on virtually all endpoints.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks